Dr. Sridhar Vijayasekaran, MD

Dr. Vijayasekaran practices at Samaritan Albany General Hospital in Albany, Oregon, part of MultiCare Health System.

Dr. Vijayasekaran's NPI, 1093762247, was assigned on May 30, 2006. Dr. Vijayasekaran holds Oregon license MD159037.

Dr. Vijayasekaran's primary practice is Samaritan Albany General Hospital, at 1046 6th Avenue SW, Albany, OR 97321 in Linn County. The practice phone is (541) 812-4000.

Dr. Vijayasekaran's primary practice is Samaritan Albany General Hospital in Albany, Oregon, part of MultiCare Health System. Dr. Vijayasekaran is also affiliated with Good Samaritan Regional Medical Center. The medical group on file is Good Samaritan Regional Medical Center. Dmand AI also links Dr. Vijayasekaran to 3 more hospitals, 4 medical groups, 3 group practices and clinics and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vijayasekaran practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Vijayasekaran's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Vijayasekaran is licensed in Oregon.

CMS data shows 2,867 Medicare services from Dr. Vijayasekaran across 19 procedure codes in 2024, for 2,088 Medicare patients. Medicare paid $81,099 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 2,088 Medicare patients who saw Dr. Vijayasekaran in 2024. The largest group is 65 to 74, with 820 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vijayasekaran's median patient age at 64, with 54% women.

In 2024, Dr. Vijayasekaran wrote 5,601 Medicare Part D claims for 857 patients. 76% of them were for generic drugs. CMS names the drug for 5,416 of them, across 35 drugs with 11 or more claims each, at $1,340,307 in total drug cost. In 2023, CMS named 4,902 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Vijayasekaran for performance year 2024, reported as part of a group. Dr. Vijayasekaran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vijayasekaran as offering telehealth.

CMS Open Payments shows 21 general payments to Dr. Vijayasekaran from 5 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 67% of the total. Abbott Laboratories paid the most, $1,999.